EPIdemiological Approaches to the Cardiovascular Consequences of COVID-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

35 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-03-15

Study Completion Date

2021-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The COVID-19 pandemic highlights the importance of the prognosis of co-morbidities, such as coronary artery disease, which significantly increase the risk of mortality in patients infected with SARS-CoV2. Investigators have recently studied the complex links between respiratory infections, particularly pneumonia, and type 2 myocardial infarction (MI) in many respects. The etiology of type 2 MI is based on an imbalance of myocardial oxygen supply/need in the absence of rupture/erosion of atheromatous plaques. Based on the RICO survey data, the investigators investigated whether COVID-19-related sepsis and/or respiratory failure could be an underlying mechanism of MI2.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

MYocardial DOmmages Related to COVID-19

NCT04498065

Covid19 Non Ischemic Myocardial Injury Myocardial Infarction +2 more

COMPLETED

Prognostic and Clinical Impact of Cardiovascular Involvement in Patients With COVID-19

NCT04624503

Covid19 Myocardial Injury Cardiovascular Diseases +2 more

UNKNOWN

Cardiovascular Complications and COVID-19 (CovCardioVasc-Study)

NCT04335162

COVID Acute Coronary Syndrome Myocardial Infarction +4 more

COMPLETED

Cardiovascular Disease and Outcomes Among Patients With SARS-CoV-2 Infection (COVID-19)

NCT05085262

COVID-19 Respiratory Infection

UNKNOWN

Impact of Initial Diagnosis on Mortality for Patients Hospitalised With Acute Myocardial Infarction

NCT02600962

ST-elevation Myocardial Infarction Non ST-elevation Myocardial Infarction

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Myocardial Infarction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A

Type 2 MI with COVID-19

Biological data

Intervention Type BIOLOGICAL

Biological data

Clinical data

Intervention Type OTHER

Clinical data

B

Type 2 without COVID-19

Biological data

Intervention Type BIOLOGICAL

Biological data

Clinical data

Intervention Type OTHER

Clinical data

C

Type 2 MI with pneumonia without COVID-19

Biological data

Intervention Type BIOLOGICAL

Biological data

Clinical data

Intervention Type OTHER

Clinical data

D

Type 2 MI without pneumonia and without COVID-19

Biological data

Intervention Type BIOLOGICAL

Biological data

Clinical data

Intervention Type OTHER

Clinical data

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Biological data

Intervention Type BIOLOGICAL

Clinical data

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients hospitalized for a type 2 MI in CCU from CHU Dijon Bourgogne With or without pneumonia
* patients hospitalized for a type 2 MI in CCU from CHU Dijon Bourgogne With or without COVID 19